CD44 and breast cancer: Finally, they analyzed the miR-373 expression in breast cancer clinical specimens and found a significant up-regulation of miR-373 in 11 matched normal/tumor samples, which inversely correlated with CD44 expression, in particular in tumors exhibiting lymph node metastasis.